Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Dolby Laboratories Sees Q4 Adj EPS $0.61-$0.76 vs $0.77 Est; Sees Sales $288.000M-$318.000M vs $310.12M Est

Author: Benzinga Newsdesk | July 31, 2025 03:17pm
Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $0.61-$0.76 vs $0.77 analyst estimate. sees sales of $288.000 million-$318.000 million vs $310.12 million analyst estimate.

Posted In: DLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist